![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 471/10 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61K 31/437 | (2006.01) | ||
A61P 9/08 | (2006.01) |
(11) | Number of the document | 2638042 |
(13) | Kind of document | T |
(96) | European patent application number | 11787987.4 |
Date of filing the European patent application | 2011-11-10 | |
(97) | Date of publication of the European application | 2013-09-18 |
(45) | Date of publication and mention of the grant of the patent | 2014-09-24 |
(46) | Date of publication of the claims translation | 2014-12-29 |
(86) | Number | PCT/US2011/060081 |
Date | 2011-11-10 |
(87) | Number | WO 2012/064910 |
Date | 2012-05-18 |
(30) | Number | Date | Country code |
201061425034 P | 2010-12-20 | US | |
413077 P | 2010-11-12 | US |
(72) |
BELL, Ian, M., US
FRALEY, Mark, E., US
GALLICCHIO, Steven, N., US
GINNETTI, Anthony, US
MITCHELL, Helen, J., US
PAONE, Daniel, V., US
STAAS, Donnette, D., US
WANG, Cheng, US
ZARTMAN, C. Blair, US
STEVENSON, Heather, E., US
|
(73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Piperidinonkarboksamidazaindanai, kaip CGRP-receptoriaus antagonistai |
PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS |
Payment date | Validity (years) | Amount | |
2024-10-11 | 14 | 289.00 EUR |
2025-11-10 |